Following its review of D-ribose, EFSA concluded that D-ribose is safe for the general population, including children, at a daily dose of 2.5 g-a dosage the company calls “a strong dose for efficacy.”
Bioenergy Life Science's (Minneapolis) trademark energy ingredient, Bioenergy Ribose, has gained a positive opinion from the European Food Safety Authority (EFSA) designating the ingredient as a novel food. Following its review of D-ribose, EFSA concluded that D-ribose is safe for the general population, including children, at a daily dose of 2.5 g-a dosage the company calls “a strong dose for efficacy.”
“We have worked very hard for this achievement and are very happy we have the safety approval from EFSA to use Bioenergy Ribose in food and beverage applications in the EU,” said Marianne McDonagh, vice president of sales for Bioenergy Life Science, in a statement. “We look forward to continue working with the EU Commission to define the list of food categories and expanding our brand and core product, Bioenergy Ribose, in Europe.”
Bioenergy Ribose has already been used in dietary supplements for nearly 30 years in Europe, the company says. In the United States, it is FDA-GRAS affirmed and has been in the market for more than 40 years, the company says.
D-Ribose, also known as ribose, is the “backbone” of the ATP molecule, playing an integral role in how quickly the body can rebuild ATP stores. Supplementation with ribose is beneficial because although the body’s cells produce ribose, the metabolic pathway for doing so is slow, the firm says.
With its energy-supporting capabilities, Bioenergy Ribose has been shown to help accelerate energy recovery, reduce muscle stiffness, and improve endurance. It is suited for supporting everything from heart health, sports nutrition, and weight management to healthy aging and more. Bioenergy Ribose is also kosher, halal, gluten free, and Non-GMO Project Verified.